Jenny Chaplin

Jenny Chaplin

Jenny Chaplin has more than twenty years of experience in program management and corporate operations.  Her expertise includes planning and execution of drug development programs from research through late-stage development; portfolio and scenario analysis; managing alliances and partnerships; and building solutions for efficiency across R&D and G&A.

Jenny’s experience spans large pharma to smaller, early-stage biotech. She was most recently Vice President, Strategic Operations, at Bellicum Pharmaceuticals before founding Saffyre Consulting.  Prior to this she held positions of increasing responsibility at Pfizer, Vical Inc, and Diversa Corp.  Her drug development expertise spans cell therapies, vaccines, other biologicals, and small molecules.  Jenny has a strong track record of organizational excellence and translating strategy into execution.  She has delivered multiple projects on target, managed challenging global alliances, and successfully taken on diverse operational leadership roles.

Jenny has an enthusiasm for working with early-stage companies and setting them up for success with integrated and adaptive development plans.  She provides guidance on the development pathway, product selection, target product profiles, and opportunity and risk assessment.  She also plays a key role in managing partner and vendor relationships and establishing stage-appropriate workflows within early-stage companies to improve productivity and support future growth.

Jenny holds a B.Sc (Hons) from the University of the Witwatersrand.  She has published several papers and has held >5 patents. She is a former Chapter President for AWIS-San Diego, has served as a mentor for both HBA and WIB programs, an advisor for Chico State University’s Women in Leadership Program and for SpringBoard Enterprises.